Biomarkers – Webinars and Online Events

This webinar introduces a streamlined, scalable workflow that simplifies FFPE sample preparation, enhancing efficiency and reproducibility for large-cohort studies and unlocking new opportunities for high-throughput biomarker discovery.

This webinar will compare six leading plasma proteomic technologies, providing insights into their performance and applications.

Join us on March 24 for an exclusive Ask Me Anything session with Dr. Robert Osborne, Senior Vice President of R&D at biomodal, as we delve into the cutting-edge field of Epigenetic Biomarkers for Early Disease Detection.

In this webinar, our speaker will discuss the challenges and opportunities in measuring cfDNA from liquid samples and the role of magnetic beads in this process.

In this webinar, Dr. Eugenia Kuteeva will explore how Atlas Antibodies, developed from the Human Protein Atlas, can support biomarker discovery, improve patient stratification and refine therapeutic targeting in precision oncology.

In this webinar, our expert speaker will explore a novel technology with high multiplexing capacity that enables the simultaneous detection of multiple targets in a single reaction, accelerating biomarker discovery and precision diagnostics.

Our expert speaker will explore the need to progress from the one-assay-one-gene paradigm, how to include quality control steps and discuss the importance of biological variation checking prior to statistical testing.

This webinar explores the precision and correlation of leading large-scale proteomic platforms, providing essential insights for human plasma proteome profiling.

This webinar explores a microfluidics approach to quantify AMP gene expression, providing insights into potential biomarkers for early disease detection and improved treatment strategies.

Learn about the latest research in spatial biology and its applications. From understanding the mechanisms of infectious disease to early diagnostics and therapeutics, hear the outstanding advancements in the field.